euroPLX 45 Lisbon

euroPLX Meetings are the place for pharma deals, attended by industry executives in charge of business development, commercial operations, marketing, and brokers or consultants with clear mandates. euroPLX delivers an average of more than 23 pre-scheduled appointments per participating company.

Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this event. It evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution. It will be displayed on this page as soon as a sufficient number of collaboration interests are submitted.

In addition, attending companies may offer or look for R&D services, supporting technologies (new drug delivery; medical devices), contract manufacture, and, to some extent, the supply of APIs and intermediates.

Registration fee: 1,300 Euro per delegate (regular). Special conditions for early registrations and for multiple registrations.

Limited to about 100-120 companies (one or several delegates)

Registration period until February 10, 2011 (no registrations after this date - except for additional delegates of already registered companies)